NASDAQ · RENX

RenX Enterprises Corp.

$1.97 -$0.03 (-1.50%) 1D After hours

Key Metrics

$5.23M
Market cap
P/E · TTM
$12.16M
Revenue · TTM
−$23.11M
Net income
EPS · TTM $-229.78
Dividend yield
Free cash flow −$12.86M
Beta · 1Y 1.67
EBITDA · TTM −$12.36M
Gross margin 30.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 19
    From its Feb 11 high, the share price fell 67%.

    Peak close $4.24 on Feb 11; trough close $1.42 on May 19. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -67%
  • Apr 1
    The stock moved +46.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 1
  • Feb 11
    The stock moved +51.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.23M
Enterprise value
Shares outstanding2.6M
52-wk range$0.16 – $7.00
Avg volume · 20D2.2M
Net cash
Book value / share$12.29
IndustryRefuse Systems
ExchangeNASDAQ
About RenX Enterprises Corp.
IPO dateSep 19, 2023
Employees38

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.43
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 30.6%
Operating -114.8%
Net -190.0%
FCF -105.7%
ROE / ROIC -2,212.3% · —

Financial Health

Current ratio0.11
Quick ratio0.07
Debt / equity20.25
Debt / EBITDA -2.03
Net cash
Working capital−$26.80M

Cash Flow · TTM

Operating CF −$8.73M
Capex −$4.12M
Free cash flow −$12.86M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-3.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings